Vascular endothelial growth factor and its soluble receptor in ovarian pathology

By Artini PG   Cristello F   Monti M   Cela V   Battaglia C   D'Ambrogio G   Genazzani AR  

Gynecological Endocrinology, Vol. 21, Iss. 1, 2005-07 ,pp. : 50-56

Informa Healthcare

Access to resources Recommend Favorite

Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome

By Villasante A.   Pacheco A.   Pau E.   Ruiz A.   Pellicer A.   Garcia-Velasco J.A.  

Human Reproduction, Vol. 23, Iss. 3, 2008-03 ,pp. : 662-667

Oxford University Press

Access to resources Recommend Favorite

Poor responder–high responder: the importance of soluble vascular endothelial growth factor receptor 1 in ovarian stimulation protocols

By Neulen Joseph  

Human Reproduction, Vol. 16, Iss. 4, 2001-04 ,pp. : 621-626

Oxford University Press

Access to resources Recommend Favorite

Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation

By Artini Paolo   Monti Massimiliano   Matteucci Cristiana   Valentino Valeria   Cristello Francesca   Genazzani Andrea  

Gynecological Endocrinology, Vol. 22, Iss. 8, 2006-08 ,pp. : 465-470

Informa Healthcare

Access to resources Recommend Favorite

Increased risk of ovarian hyperstimulation syndrome following controlled ovarian hyperstimulation in patients with vascular endothelial growth factor +405 cc genotype

By Hanevik Hans Ivar   Hilmarsen Hilde Tveitan   Skjelbred Camilla Furu   Tanbo Tom   Kahn Jarl A.  

Gynecological Endocrinology, Vol. 28, Iss. 11, 2012-11 ,pp. : 845-849

Informa Healthcare

Access to resources Recommend Favorite